Figure 1
SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. (A,B) Neutrophils were incubated with (□) or without (■) 10 μg/mL SSL5 for 30 seconds and stimulated with (A) 1 nM fMLP, 10 nM MMK-1, 0.1 nM PAF, 0.1 nM LTB4, 3 nM C3a, 0.1 nM C5a, or 0.5 nM IL-8 and with (B) 30 nM ionomycin or 1 μM ATP. Cell activation was measured by calcium mobilization (C-K). Neutrophils (C-F) or monocytes (G-K) were preincubated with 0 (■), 1 (▴), 3 (▾), or 10 (♦) μg/mL SSL5 for 30 seconds. Calcium mobilization was measured on stimulation with C3a (C), C5a (D), CXCL8 (E), CXCL1 (F), CXCL12 (G), CCL2 (H), CCL3 (I), CCL5 (J), or CX3CL1 (K). Results represent mean plus or minus SEM of 3 independent experiments and are expressed relative to buffer-treated cells.

SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. (A,B) Neutrophils were incubated with (□) or without (■) 10 μg/mL SSL5 for 30 seconds and stimulated with (A) 1 nM fMLP, 10 nM MMK-1, 0.1 nM PAF, 0.1 nM LTB4, 3 nM C3a, 0.1 nM C5a, or 0.5 nM IL-8 and with (B) 30 nM ionomycin or 1 μM ATP. Cell activation was measured by calcium mobilization (C-K). Neutrophils (C-F) or monocytes (G-K) were preincubated with 0 (■), 1 (▴), 3 (▾), or 10 (♦) μg/mL SSL5 for 30 seconds. Calcium mobilization was measured on stimulation with C3a (C), C5a (D), CXCL8 (E), CXCL1 (F), CXCL12 (G), CCL2 (H), CCL3 (I), CCL5 (J), or CX3CL1 (K). Results represent mean plus or minus SEM of 3 independent experiments and are expressed relative to buffer-treated cells.

Close Modal

or Create an Account

Close Modal
Close Modal